Nicotine gum + Placebo gum + Nicotine inhaler + Placebo inhaler
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
Feb 1, 1999 → May 1, 2000
NCT ID
NCT00840242About Nicotine gum + Placebo gum + Nicotine inhaler + Placebo inhaler
Nicotine gum + Placebo gum + Nicotine inhaler + Placebo inhaler is a phase 3 stage product being developed by Johnson & Johnson for Smoking Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT00840242. Target conditions include Smoking Cessation.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00840242 | Phase 3 | Completed |
Competing Products
20 competing products in Smoking Cessation